rs201364852
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_022124.6(CDH23):c.5038G>A(p.Val1680Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000849 in 1,613,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000883 AC: 22AN: 249278Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135188
GnomAD4 exome AF: 0.0000540 AC: 79AN: 1461690Hom.: 0 Cov.: 33 AF XY: 0.0000481 AC XY: 35AN XY: 727136
GnomAD4 genome AF: 0.000381 AC: 58AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74252
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 05, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The CDH23 p.Val1680Ile variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs201364852) and ClinVar (classified as likely benign by Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine). The variant was also identified in control databases in 35 of 280646 chromosomes at a frequency of 0.000125 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 22 of 24270 chromosomes (freq: 0.000907), European (non-Finnish) in 9 of 128346 chromosomes (freq: 0.00007), Latino in 2 of 35374 chromosomes (freq: 0.000057), East Asian in 1 of 19532 chromosomes (freq: 0.000051), and South Asian in 1 of 30600 chromosomes (freq: 0.000033), while the variant was not observed in the Ashkenazi Jewish, European (Finnish), or other populations. The p.Val1680 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing at the variant location. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 28, 2013 | Val1680Ile in Exon 39 of CDH23: This variant is not expected to have clinical si gnificance because the valine (Val) residue at position 1680 is poorly conserved across species, with many vertebrate, mammalian and primate species (including chimpanzee, gorilla, and orangutan) having an isoleucine (Ile) at this position. In addition, it has been identified in 0.01% (1/8566) of European American chr omosomes and 0.05% (2/4382) of African American chromosomes from a broad populat ion by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; db SNP rs201364852). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at